FeaturedNeurologyNeuroscience·June 7, 2021·3 min readFDA Grants Accelerated Approval for Alzheimer’s Drug – AduhelmAduhelm, a new drug that appears to reduce amyloid plaques in the brain, is the first new Alzheimer's disease medication to be approved since 2003, and is the first drug that targets the fundamental pathology of the disease.Read More
FeaturedNeurology·September 19, 2016·4 min readFirst Drug to Treat Duchenne Muscular Dystrophy Approved by FDAThe FDA have approved the first drug designed to treat patients with Duchenne muscular dystrophy.Read More